Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite

A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology

By Zhang Y.   Li H.-L.   Wang D.-L.   Liu S.-J.   Wang J.-Z.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1487-1497

Springer Publishing Company

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M.   Venu R.   Somashekhar R.  

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

By Buerger Katharina   Ewers Michael   Zinkowski Raymond   Alafuzoff Irina   Teipel Stefan J.   DeBernardis John   Kerkman Daniel   McCulloch Cheryl   Soininen Hilkka   Hampel Harald  

Brain, Vol. 129, Iss. 11, 2006-11 ,pp. : 3035-3041

Oxford University Press

Access to resources Recommend Favorite

Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs

By Attems Johannes   Quass Magdalena   Jellinger Kurt  

Acta Neuropathologica, Vol. 113, Iss. 1, 2007-01 ,pp. : 53-62

Springer Publishing Company

Access to resources Recommend Favorite